Everence Capital Management’s Labcorp LH Stock Holding History

Everence Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35M	Hold	4,820	–	–	0.07%	210
2026 Q1	$1.29M	Hold	4,820	–	–	0.08%	208
2025 Q4	$1.21M	Hold	4,820	–	–	0.07%	210
2025 Q3	$1.38M	Hold	4,820	–	–	0.08%	187
2025 Q2	$1.26M	Hold	4,820	–	–	0.08%	198
2025 Q1	$1.12M	Hold	4,820	–	–	0.08%	209
2024 Q4	$1.1M	Buy	4,820 +2,710	+128%	+$622K	0.07%	212
2024 Q3	$472K	Sell	2,110 -3,300	-61%	-$725K	0.03%	442
2024 Q2	$1.09M	Hold	5,410	–	–	0.08%	209
2024 Q1	$1.18M	Sell	5,410 -1,890	-26%	-$416K	0.08%	206
2023 Q4	$1.66M	Buy	7,300 +3,290	+82%	+$691K	0.12%	163
2023 Q3	$806K	Buy	4,010 +1,542	+62%	+$325K	0.06%	255
2023 Q2	$451K	Hold	2,468	–	–	0.04%	379
2023 Q1	$486K	Hold	2,468	–	–	0.04%	374
2022 Q4	$499K	Sell	2,468 -2,398	-49%	-$469K	0.04%	371
2022 Q3	$856K	Hold	4,866	–	–	0.08%	217
2022 Q2	$980K	Buy	4,866 +722	+17%	+$154K	0.09%	188
2022 Q1	$939K	Hold	4,144	–	–	0.07%	225
2021 Q4	$1.12M	Hold	4,144	–	–	0.08%	204
2021 Q3	$1M	Hold	4,144	–	–	0.08%	202
2021 Q2	$982K	Hold	4,144	–	–	0.08%	204
2021 Q1	$908K	Hold	4,144	–	–	0.08%	198
2020 Q4	$725K	Buy	4,144 +1,676	+68%	+$289K	0.07%	234
2020 Q3	$399K	Buy	+2,468	New	+$391K	0.04%	365
2017 Q4	–	Sell	-3,108	Closed	-$403K	–	435
2017 Q3	$403K	Hold	3,108	–	–	0.09%	252
2017 Q2	$412K	Hold	3,108	–	–	0.1%	245
2017 Q1	$383K	Hold	3,108	–	–	0.1%	246
2016 Q4	$343K	Buy	+3,108	New	+$345K	0.1%	243

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Everence Capital Management's LH Position: Q2 2026 in Review

Everence Capital Management held its Labcorp (LH) position steady in Q2 2026 at 4,820 shares worth $1.35M. The position accounts for 0.07% of the portfolio, ranked #210.

Everence Capital Management first reported a position in LH in Q4 2016 and has held it in 28 quarters since. The position peaked at $1.66M in Q4 2023. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Everence Capital Management held 4,820 shares of Labcorp worth $1.35M as of Q2 2026.
Everence Capital Management left its Labcorp share count unchanged in Q2 2026.
Labcorp made up 0.07% of Everence Capital Management's portfolio in Q2 2026, its #210 holding.
Everence Capital Management first reported a position in Labcorp in Q4 2016 and has held it in 28 quarters since.
Everence Capital Management's Labcorp position peaked at $1.66M in Q4 2023.
1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.